Envestnet Asset Management Inc Procept Bio Robotics Corp Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 37,273 shares of PRCT stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,273
Previous 42,202
11.68%
Holding current value
$2.15 Million
Previous $3.4 Million
36.11%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
301Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$295 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$201 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$123 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$81.5 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$68.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.57B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...